BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48
Published . Updated .
The average one-year price target for BlossomHill Therapeutics (NASDAQGS:BLSM) has been revised to $37.48 / share. This is an increase of 10.53% from the prior estimate of $33.92 dated September 11, 2026. These figures represent an aggregate of analyst targets compiled by Fintel
Directly affected
- BLSM BlossomHill Therapeutics
Named in this report.
Indirectly affected
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for BlossomHill Therapeutics (NASDAQGS:BLSM) has been revised to $37.48 / share. This is an increase of 10.53% from the prior estimate of $33.92 dated September 11, 2026. These figures represent an aggrega…
Source: Nasdaq Markets
Price since this story was published: T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ)
Since the first closing price after “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is +9.68%. The S&P 500 fund (SPY) is -1.08% over the same days, a +10.76% difference versus the market.
Who gains and who loses around T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ)
Companies mentioned with this story
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
In “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
In “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48.” Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
In “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
In “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDE Ishares Lifepath Target Date 2045 Etf Usd
In “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48,” Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ)
The 2 Oct 2026 story “BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48” names T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) because of this story.
What ties T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) to the headline is this: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Ft Vest Djia Dogs 10 Target Income Etf (DOGG), is listed for a different reason: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ)
BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99. FGSI traded between 20.20 and 20.62 across 5 sessions. The latest close on file is 20.27.
What the saved facts support for T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ)
46 out of 100
“BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.